Clinical trials recruiting for Malignant Pleural Effusion
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| locally manufactured adoptive cellular therapy (ACT) product | 2 |
| Interleukin-2 | 1 |
| Interleukin-2 (IL-2) | 1 |
| MT027 cells suspension | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Pennsylvania | 2 |
| North Carolina | 1 |
Top cities
Self-screener
Recruiting trials
- A Study of MT027 in Patients with Pleural Malignant Tumors
- Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease
- Fast TILs to Treat Metastatic Pleural Effusions From Epithelial or Mesothelial Primary Tumors
- Oncodrivers in Malignant Pleural Effusions Associated With Non-small Cell Lung Cancer: A Prospective Study.
- UNC Pleural Fluid Registry
Related conditions
Trials recruiting for Malignant Pleural Effusion often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Malignant Pleural Effusion trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.